Our GLP-1 Daily Support supplement is available for immediate purchase to complement your regimen and support metabolic health
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
GLP-1 drugs are stronger and longer-lasting than the body's natural GLP-1 hormone, says Janelle Duah, MD, associate medical director at Maven Clinic, a virtual clinic of women's and family health, based in New Haven, Connecticut
Similarly, a medication that produces no injection site reactions at all is not necessarily working better
This product is not a drug, supplement, or food product and has not been evaluated by the FDA
Outstanding Support: The vendors professional support team is highly knowledgeable about peptides and is sure to address all concerns as quickly as possible